We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+23.43%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$16.4B
AUM Growth
-$5.58B
(-25%)
Cap. Flow
-$3.87B
Cap. Flow
% of AUM
-23.65%
Top 10 Holdings %
Top 10 Hldgs %
18.07%
Holding
3,458
New
283
Increased
974
Reduced
1,077
Closed
907
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$97.1M |
| 2 |
iShares Core S&P Small-Cap ETF
IJR
|
+$76.6M |
| 3 |
Lowe's Companies
LOW
|
+$75.4M |
| 4 |
Monster Beverage
MNST
|
+$64.6M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$63.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$114M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$109M |
| 3 |
Trane Technologies
TT
|
+$106M |
| 4 |
Microsoft
MSFT
|
+$104M |
| 5 |
Mastercard
MA
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.03% |
| 2 | Healthcare | 13.89% |
| 3 | Financials | 11.27% |
| 4 | Consumer Discretionary | 8.92% |
| 5 | Industrials | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Crown Holdings
CCK
$12.9B
| $14K | ﹤0.01% |
230
-400
| -63% | -$25.2K |
|
1727
Corcept Therapeutics
CORT
$12.8B
| $14K | ﹤0.01% |
868
-201
| -19% | -$2.82K |
|
|
CYBR
1728
DELISTED
CyberArk
CYBR
| $14K | ﹤0.01% |
148
+132
| +825% | +$12.8K |
|
1729
Invesco Zacks Mid-Cap ETF
CZA
$190M
| $14K | ﹤0.01% |
233
| – | – |
|
1730
DigitalBridge
DBRG
$2.93B
| $14K | ﹤0.01% |
1,504
+94
| +7% | +$816 |
|
1731
Dine Brands
DIN
$457M
| $14K | ﹤0.01% |
366
+173
| +90% | +$6.98K |
|
1732
Encore Capital Group
ECPG
$2.02B
| $14K | ﹤0.01% |
416
+147
| +55% | +$4.38K |
|
1733
Equity Residential
EQR
$25.2B
| $14K | ﹤0.01% |
244
-172
| -41% | -$10.7K |
|
1734
iShares MSCI United Kingdom ETF
EWU
$4.17B
| $14K | ﹤0.01% |
575
+297
| +107% | +$7.51K |
|
1735
Franklin Covey
FC
$243M
| $14K | ﹤0.01% |
675
-602
| -47% | -$12.2K |
|
1736
Heritage Financial
HFWA
$1.21B
| $14K | ﹤0.01% |
724
+393
| +119% | +$7.41K |
|
1737
Kelly Services Class A
KELYA
$521M
| $14K | ﹤0.01% |
914
+426
| +87% | +$6.09K |
|
1738
Strategy Inc
MSTR
$35.7B
| $14K | ﹤0.01% |
1,260
+480
| +62% | +$5.84K |
|
|
ADAM
1739
Adamas Trust
ADAM
$804M
| $14K | ﹤0.01% |
1,396
+483
| +53% | +$4.24K |
|
1740
OneSpan
OSPN
$571M
| $14K | ﹤0.01% |
521
+321
| +161% | +$6.3K |
|
1741
Peloton Interactive
PTON
$2.76B
| $14K | ﹤0.01% |
250
+30
| +14% | +$1.24K |
|
1742
Sabra Healthcare REIT
SBRA
$5.38B
| $14K | ﹤0.01% |
985
| – | – |
|
1743
Sprouts Farmers Market
SFM
$8.1B
| $14K | ﹤0.01% |
563
+509
| +943% | +$11.6K |
|
1744
Skywest
SKYW
$4.29B
| $14K | ﹤0.01% |
444
+35
| +9% | +$1.04K |
|
1745
Trip.com Group
TCOM
$29.3B
| $14K | ﹤0.01% |
567
-7,365
| -93% | -$186K |
|
1746
Gentherm
THRM
$1.3B
| $14K | ﹤0.01% |
360
-46
| -11% | -$1.74K |
|
1747
Travere Therapeutics
TVTX
$5.33B
| $14K | ﹤0.01% |
721
-94
| -12% | -$1.5K |
|
1748
United Natural Foods
UNFI
$3.01B
| $14K | ﹤0.01% |
801
+555
| +226% | +$8.32K |
|
1749
Wabash National
WNC
$505M
| $14K | ﹤0.01% |
1,372
-254
| -16% | -$2.24K |
|
1750
Western New England Bancorp
WNEB
$262M
| $14K | ﹤0.01% |
2,500
| – | – |
|
Similar funds
EWA
MIC
P
OSAM
CB
EIM
SC
Glenmede Trust's Q2 2020 Portfolio in Review
As of Q2 2020, Glenmede Trust held 3,458 positions worth $16.4B, down 25% from $21.9B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Glenmede Trust withdrew a net $3.87B in Q2 2020, closing 907 positions and reducing 1,077 holdings. Its most notable exit was Raytheon Company, an estimated $66.5M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Glenmede Trust opened a new position in Carrier Global worth $21.3M.
- Glenmede Trust's largest Q2 2020 buy was Carrier Global: 960,042 shares worth $21.3M.
- Glenmede Trust added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $97.1M increase.
- Glenmede Trust's biggest Q2 2020 reduction was Accenture, cutting an estimated $114M.
- Glenmede Trust fully exited Raytheon Company in Q2 2020, selling an estimated $66.5M.
- Glenmede Trust's ten largest holdings make up 18% of its $16.4B portfolio in Q2 2020.
- Glenmede Trust opened 283 new positions and closed 907 in Q2 2020.
- Glenmede Trust's portfolio value fell 25% quarter-over-quarter to $16.4B.
Based on Glenmede Trust's 13F filing for Q2 2020, filed 14 Aug 2020.